Back to User profile » Dr Seval Kul

Papers published by Dr Seval Kul:

Original Research

Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients

Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5603-5609

Published Date: 9 September 2016

Original Research

Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel

Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5073-5080

Published Date: 12 August 2016

Original Research

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study

Aktas G, Kus T, Kalender ME, Sevinc A, Camci C, Kul S

OncoTargets and Therapy 2016, 9:1921-1926

Published Date: 1 April 2016

Original Research

Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C

OncoTargets and Therapy 2015, 8:3749-3756

Published Date: 15 December 2015